PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $10,021,000 | -10.9% | 722,523 | 0.0% | 0.28% | -33.9% |
| Q4 2018 | $11,250,000 | -23.6% | 722,523 | -5.1% | 0.43% | +8.6% |
| Q3 2018 | $14,725,000 | +579.5% | 761,000 | +661.0% | 0.39% | +116.5% |
| Q4 2014 | $2,167,000 | +26.1% | 100,000 | 0.0% | 0.18% | -1.6% |
| Q3 2014 | $1,719,000 | – | 100,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |